ImmuCell (NASDAQ:ICCC) issued its earnings results on Monday. The biotechnology company reported ($0.09) EPS for the quarter, Bloomberg Earnings reports. The firm had revenue of $2.71 million during the quarter. ImmuCell had a negative return on equity of 5.71% and a negative net margin of 15.62%.
Shares of ICCC stock opened at $6.01 on Wednesday. ImmuCell has a one year low of $5.55 and a one year high of $9.30. The business has a fifty day moving average price of $6.24. The company has a debt-to-equity ratio of 0.27, a current ratio of 7.26 and a quick ratio of 6.25.
See Also: Percentage Gainers
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.